Journals / Gülhane Tıp Dergisi / 2010 / Cilt: 52 - Sayı: 2

A different clinical presentation of salt wasting in the case report of twins: Selective hypoaldosteronism

İkiz olgu raporunda tuz kaybının farklı klinik yansıması: İzole hipoaldosteronizm

Pages
143–147
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It should be kept in mind that selective hypoaldosteronism should be considered in the differential diagnosis of salt-losing pathologies in the neonatal period, and patients may present with different clinical findings in the first month of life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Selective hypoaldosteronism is a rare cause of life-threatening salt wasting in the neonatal period.
📊
Key Findings & Data:In this case report, twin premature newborns who were diagnosed with different clinical presentations with hyperkalemia and hyponatremia in the first and 5th months of life are presented.
💡
Conclusion & Impact:It should be kept in mind that selective hypoaldosteronism should be considered in the differential diagnosis of salt-losing pathologies in the neonatal period, and patients may present with different clinical findings in the first month of life.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Selective hypoaldosteronism is a rare cause of life-threatening salt wasting in the neonatal period. Patients are most frequently diagnosed with the clinical signs of aldosterone deficiency during the first week of life. In this case report, twin premature newborns who were diagnosed with different clinical presentations with hyperkalemia and hyponatremia in the first and 5th months of life are presented. The electrolyte values of the twin cases diagnosed to have selective hypoaldosteronism improved rapidly after administration of oral salt (NaCl) and fludrocortisone treatments. It should be kept in mind that selective hypoaldosteronism should be considered in the differential diagnosis of salt-losing pathologies in the neonatal period, and patients may present with different clinical findings in the first month of life.

Özet

İzole hipoaldosteronizm, yenidoğan döneminde yaşamı tehdit eden tuz kaybının nadir bir nedenidir. Hastalar sıklıkla yaşamın ilk haftasında aldosteron eksikliğinin klinik bulguları ile tanı alırlar. Bu olgu sunumunda, hiperkalemi ve hiponatreminin eşlik ettiği yaşamın 1. ve 5. ayında farklı klinik bulgularla tanı alan ikiz prematüre olgular sunulmuştur. İzole aldosteron eksikliği tanısı alan ikiz olgulara oral tuz (NaCl) ve fludrokortizon tedavisi uygulanması sonrası elektrolit değerleri hızla normale döndü. İzole aldosteron eksikliği, yenidoğan döneminde tuz kaybı ile giden patolojilerin ayırıcı tanısında düşünülmeli ve yaşamın ilk ayında farklı klinik bulgularla başvurabilecekleri de akılda tutulmalıdır.

🔖

Cite This Article

ABACI, A., AGRAS, P. I., KIŞLAL, F., HIZLI, Ş., ÖZDEMİR, O., KOÇAK, M. (2010). A different clinical presentation of salt wasting in the case report of twins: Selective hypoaldosteronism. Gülhane Tıp Dergisi, Cilt: 52 - Sayı: 2, 143–147. https://ajindex.com/articles/226127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Kayes-Wandover KM, Tannin GM, Shulman D, et al. Congenital hyperreninemic hypoaldosteronism unlinked to the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 2001; 86: 5379-5382
  2. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med 1994; 331: 250-258
  3. White PC. Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol 2004; 217: 81-87
  4. Cinaz P. Adrenal yetmezlik tanısında kullanılan testler. In: Yordam N, Alikaşifoğlu A, Bideci A (eds). Çocuk ve Adölesanda Endokrin Testler. Pediatrik Endokrinoloji ve Oksoloji Derneği Yayınları: 2. Ankara: Öncü Basımevi, 2006: 151-173
  5. Zennaro MC, Lombes M. Mineralocorticoid resistance. Trends Endocrinol Metab 2004; 15: 264-270
  6. Peter M, Dubuis JM, Sippell WG. Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies. Horm Res 1999; 51: 211-222
  7. Lee PD, Patterson BD, Hintz RL, Rosenfeld RG. Biochemical diagnosis and management of corticosterone methyl oxidase type II deficiency. J Clin Endocrinol Metab 1986; 62: 225-229
  8. Wasniewska M, De LF, Valenzise M, Lombardo F, De LF. Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene. Eur J Endocrinol 2001; 144: 59-62
  9. Ulick S, Wang JZ, Morton DH. The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone. J Clin Endocrinol Metab 1992; 74: 1415-1420
  10. Belot A, Ranchin B, Fichtner C, et al. Pseudohypoaldosteronisms, report on a 10-patient series. Nephrol Dial Transplant 2008; 23: 1636-1641
  11. Geller DS. Mineralocorticoid resistance. Clin Endocrinol (Oxf) 2005; 62: 513-520
  12. Oberfield SE, Levine LS, Carey RM, Bejar R, New MI. Pseudohypoaldosteronism: multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab 1979; 48: 228-234
  13. Candemir M, Semiz S, Özdemir ÖMA. Kistik fibrozisli bir olguda psödo-Bartter sendromu. Turkiye Klinikleri J Pediatr 2008; 17: 194-197
  14. Nicolaidou M, Apastopoulou E, Samara V. Excretion of Sodium-24 and Barium-82 in Cystic Fibrosis. J Nucl Med 1966; 7: 153-158
  15. Torpy DJ, Stratakis CA, Chrousos GP. Familial hyperaldosteronism. Braz J Med Biol Res 2000; 33: 1149-1155
  16. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-291
  17. Stapenhorst L. 9 α-fluorohydrocortisone therapy in aldosterone synthase deficiency. Pediatr Nephrol 2005; 20: 839.